Postmenopausal hormone therapy, SERMs, and coronary heart disease in women
- PMID: 10532249
- DOI: 10.1007/BF03343619
Postmenopausal hormone therapy, SERMs, and coronary heart disease in women
Similar articles
-
Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.Cardiol Rev. 2004 Nov-Dec;12(6):287-98. doi: 10.1097/01.crd.0000131189.50041.d1. Cardiol Rev. 2004. PMID: 15476565 Review.
-
Hormone replacement therapy trials: an update.Curr Atheroscler Rep. 2002 Mar;4(2):156-60. doi: 10.1007/s11883-002-0040-4. Curr Atheroscler Rep. 2002. PMID: 11822980
-
Comparative cardiovascular effects of different progestins in menopause.Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56. Int J Fertil Womens Med. 2001. PMID: 11720197 Review.
-
Pharmacotherapy of dyslipidemia in postmenopausal women: weighing the evidence.J Womens Health Gend Based Med. 1999 Sep;8(7):901-17. doi: 10.1089/jwh.1.1999.8.901. J Womens Health Gend Based Med. 1999. PMID: 10534293 Review.
-
Primary prevention of coronary heart disease in women.Menopause Int. 2008 Mar;14(1):40-5. doi: 10.1258/mi.2007.007037. Menopause Int. 2008. PMID: 18380961
Cited by
-
A review of coumarin derivatives in pharmacotherapy of breast cancer.Curr Med Chem. 2008;15(26):2664-79. doi: 10.2174/092986708786242877. Curr Med Chem. 2008. PMID: 18991629 Free PMC article. Review.
-
Pharmacokinetics of selective estrogen receptor modulators.Clin Pharmacokinet. 2003;42(4):361-72. doi: 10.2165/00003088-200342040-00004. Clin Pharmacokinet. 2003. PMID: 12648026 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources